Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: An exploratory investigation

International Journal of Cancer

Volumn 79, Issue 4, 1998, Pages 305-311

  Coradini, Danila ^a,g   Biganzoli, Elia ^b   Boracchi, Patrizia ^e   Bombardieri, Emilio ^d   Seregni, Ettore ^d   De Palo, Giuseppe ^c   Martelli, Gabriele ^c   Di Fronzo, Giovanni ^a,f  

^a Ist Natl Per lo Stud E la Cura D   (Italy)

^b Institute of Medical Statistics and Biometry   (Italy)

^c Division of Medical Oncology   (Italy)

^d Nuclear Medicine Division   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f CNR   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN PS2; STEROID RECEPTOR;

AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CATHEPSIN D; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0031825176     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980821)79:4<305::AID-IJC1>3.0.CO;2-Z     Document Type: Article

References (21)

1. AKAIKE, H., Information theory and an extension of the maximum likelihood principle. In: Proceedings of the Second International Symposium on Information Theory, B.N. Patrov and F. Csaki (eds.). Akademia Kiado, Budapest (1973).
2. ALLEGRA, J.C., LIPPMAN, M.E., THOMPSON, E.B., SIMON, R., BABLOCK, A., GRENN, L., HOFF, K.K., DO, H.M.T., IATKEN, S.C. and WARREN, R., Oestrogen receptor status, an important variable in predicting response to endocrine therapy in metastatic breast cancer. Europ. J. Cancer, 16, 323-331 (1980).
3. BONADONNA, G., VALAGUSSA, P., ROSSI, A., TANCINI, G., BRAMBILLA, C., ZAMBETTI, M. and VERONESI, U., Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res. Treat., 5, 95-115 (1985).
4. BRADBEER, J.W. and KYNGDON, J., Primary treatment of breast cancer in elderly women with tamoxifen. Clin. Oncol., 9, 31-34 (1983).
5. CLARK, G.M. and MCGUIRE, W.L., The clinical usefulness of estrogen-receptor and other markers of hormone dependence. Proc. Royal Soc. (Edinburgh), 95B, 145-150 (1989).
6. DURRLEMAN, S. and SIMON, R., Flexible regression models with cubic splines. Stat. Med., 8, 551-561 (1989).
7. FISHER, B., REDMOND, K., FISHER, E.R. and CAPLAN, R., Relative worth of estrogen or progesterone receptors and pathological characteristics of differentiation as indicators of prognosis in node negative breast cancer patients, findings from National Adjuvant Breast and Bowel Project Protocol B-06. J. clin. Oncol., 6, 1076-1087 (1988).
8. HARRELL, F.E. JR, LEE, K.L. and MARK, D.B., Tutorial in biostatistics multivariable prognostic models, issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med., 15, 361-387 (1996).
9. JOHNSON, M.D., TORRY, J.A., LIPPMAN, H.E. and DICKSON, R.B., The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res., 53, 873-877 (1993).
10. KIDA, N., YOSHIMURA, T., MOI, K. and HAYASHI, K., Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF7) Cancer Res., 49, 3494-3498 (1989).
11. MARUBINI, E. and VALSECCHI, M.G., Analysing survival data from clinical trials and observational studies. J. Wiley, Chichester (1995).
12. MATHIEU, M., ROCHEFORT, H., BARENTON, B., PREBOIS, C. and VIGNON, F., Interaction of cathepsin D and insulin-like growth factor II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol. Endocrinol., 4, 1327-1335 (1990).
13. RAVDIN, P.M., Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res. Treat., 24, 219-226 (1993).
14. RIO, M.C., LAPAGE, P., DIEMUNSCH, P., ROITSCH, C. and CHAMBON, P., Structure primarie de la proteine humaine pS2. C.R. Acad. Sci. (Paris), 307, 825-831 (1988).
15. ROCHEFORT, H., AUGEREAU, P., BRIOZZO, P., CAPONY, F., CAVAILLES, V. and FREISS, G., Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secretion by breast cancer cells. Biochimie, 70, 943-949 (1988).
16. RONCHI, E., GRANATA, G., BRIVIO, M., CORADINI, D., MIODINI, P. and DIFRONZO, G., A double-labeling assay for simultaneous estimation and characterization of estrogen and progesterone receptors using radioiodinated estradiol and tritiated Org2058. Tumori, 72, 251-257 (1986).
17. THOMPSON, A.M., HAWKINS, R.A., ELTON, R.A., STEEL, C.M. and CHETTY, U., pS2 is an independent factor of good prognosis in primary breast cancer. Brit. J. Cancer, 68, 93-96 (1993).
18. THOR, A.D., KOERNER, F.C., EDGERTON, S.M., WOOD, W.C., STRACHER, M.A. and SCHWARTZ, L.H., pS2 expression in primary breast cancer carcinomas, relationship to clinical and histological features and survival. Breast Cancer Res. Treat., 21, 111-119 (1992).
19. VERONESI, U., BANFI, A., DEL VECCHIO, M., SACCOZZI, R., CLEMENTE, C., GRECO, M., LUINI, A., MARUBINI, E., MUSCOLINO, G. and RILKE, F., Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Europ. J. Cancer clin. Oncol., 22, 1085-1089 (1986).
20. VIGNON, F., CAPONY, F., CHAMBON, M., FREISS, G., GARCIA, M. and ROCHEFORT, H., Autocrine growth stimulation of MCF7 breast cancer cells by the estrogen-regulated 52K protein. Endocrinology, 118, 1537-1545 (1986).
21. WALKER, R.A., DENLEY, H. and DOOKERAN, R.A., Cathepsin D in breast carcinomas - the role of the stromal cell component. Oncol. Rep., 1, 227-231 (1994).